Zobrazeno 1 - 10
of 14
pro vyhledávání: '"M. G. Juarranz"'
Autor:
Pascale Vertongen, R M Solano, Jason Perret, Magali Waelbroeck, Patrick Robberecht, M. G. Juarranz
Publikováno v:
Peptides. 22:1363-1370
Inspection of the amino acid sequence of the human VPAC1 and the VPAC2 receptors after alignment of the conserved residues indicates that the second extracellular loop (EC2) is one amino acid shorter in the VPAC1 receptor due to the lack of a proline
Autor:
Pascale Vertongen, M. G. Juarranz, R M Solano, Jason Perret, Ingrid Langer, Magali Waelbroeck, Patrick Robberecht
Publikováno v:
Journal of Biological Chemistry. 276:1084-1088
We mutated the vasoactive intestinal peptide (VIP) Asp(3) residue and two VPAC(1) receptor second transmembrane helix basic residues (Arg(188) and Lys(195)). VIP had a lower affinity for R188Q, R188L, K195Q, and K195I VPAC(1) receptors than for VPAC(
Autor:
Patrick Robberecht, P. De Neef, Johnny Cnudde, M. G. Juarranz, J. Van Rampelbergh, Magali Waelbroeck, Philippe Gourlet
Publikováno v:
Molecular Pharmacology. 56:1280-1287
A vasoactive intestinal polypeptide (VIP) analog, acylated on the amino-terminal histidine by hexanoic acid (C(6)-VIP), behaved as a VPAC(2) preferring agonist in binding and functional studies on human VIP receptors, and radioiodinated C(6)-VIP was
Autor:
Philippe Gourlet, Johnny Cnudde, Jean Van Rampelbergh, M. G. Juarranz, Magali Waelbroeck, Patrick Robberecht, Phillippe De Neef
Publikováno v:
European Journal of Biochemistry. 265:449-456
In order to identify the receptor domains responsible for the VPAC1 selectivity of the VIP1 agonist, [Lys15, Arg16, Leu27] VIP (1-7)/GRF (8-27) and VIP1 antagonist, Ac His1 [D-Phe2, Lys15, Arg16, Leu27] VIP (3-7)/GRF (8-27), we evaluated their bindin
Autor:
Patrick Robberecht, Jean Van Rampelbergh, Philippe Gourlet, Magali Waelbroeck, M. G. Juarranz
Publikováno v:
Annals of the New York Academy of Sciences. 921
Autor:
J, Van Rampelbergh, M G, Juarranz, J, Perret, A, Bondue, R M, Solano, C, Delporte, P, De Neef, P, Robberecht, M, Waelbroeck
Publikováno v:
British journal of pharmacology. 130(4)
Vasoactive Intestinal Polypeptide (VIP) interacts with a high affinity to two subclasses of G protein coupled receptors named VPAC(1) and VPAC(2), and has a 3 - 10 fold preference for VPAC(1) over VPAC(2) receptors. Selective ligands for each recepto
Publikováno v:
The Prostate. 41(1)
BACKGROUND. The 28-amino-acid neuropeptide vasoactive intestinal peptide (VIP) might play an important role in the physiology of the prostate, since it stimulates glandular secretion, inhibits muscle contraction, stimulates proliferation of epithelia
Publikováno v:
Alcoholism, clinical and experimental research. 23(2)
We studied the modifications of the vasoactive intestinal peptide (VIP) receptor/effector system from the rat seminal vesicle after chronic ethanol ingestion. Ethanol treatment resulted in a decreased height of the secretory epithelium of seminal ves
Publikováno v:
The Prostate. 36(4)
The possibility that long-term ethanol ingestion might alter either vasoactive intestinal peptide (VIP) content, VIP binding to membrane receptors, G-protein levels or adenylate cyclase activity in rat prostate was tested, as ethanol produces serious
Publikováno v:
Cellular signalling. 9(6)
The expression of alpha s, alpha i1 and alpha i2 G-protein subunits measured by immunoblot increased in the rat prostate during sexual maturation, supporting their involvement in proliferation/differentiation. Northern blotting gave transcripts of 1.